Marissa M. Alejandria
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Marissa M. Alejandria has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Maria Sonia S. Salamat
Univ Philippines, Dept Med, Div Infect Dis, UP Manila,Philippine Gen Hosp, Manila, Philippines
2 shared publications- Adovich Sarmiento Rivera
Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
1 shared publication - Anna Flor G. Malundo
Division of Infectious Diseases, University of the Philippines - Philippine General Hospital, Taft Avenue, Ermita, Manila, National Capital Region, Philippines
1 shared publication Anna Marie Celina G. Garfin
Affiliation Department of Health, National TB Control Program, Manila, Philippines
1 shared publication- Barnaby Edward Young
National Centre for Infectious Diseases, Singapore, Singapore
1 shared publication - Concepcion F. Ang
Affiliation Foundation for the Control of Infectious Diseases, Taft Avenue, Manila, Philippines
1 shared publication
Latest Publications
- Open Access
- 12 January 2025
- Published by National University of Singapore Press
- p. 365-378
Enabling research for therapeutics
Research is a vital part of the effective response to a disease outbreak. Given the wide spectrum of potential outbreaks and the varying therapeutic research questions, it is challenging to develop a generic, broadly applicable clinical trial protocol as part of outbreak research preparedness. However, when considering approaches, there are common threads which can be pulled together and examples of best practice which have facilitated an effective outbreak response via research in the past. These can be replicated or adapted. This chapter will consider these common themes and discuss relevant examples that can facilitate timely, relevant, and clinically meaningful research on therapeutics during an outbreak.
- 12 January 2025
- Published by National University of Singapore Press
- p. 365-378
Open AccessEnabling research for therapeutics
Research is a vital part of the effective response to a disease outbreak. Given the wide spectrum of potential outbreaks and the varying therapeutic research questions, it is challenging to develop a generic, broadly applicable clinical trial protocol as part of outbreak research preparedness. However, when considering approaches, there are common threads which can be pulled together and examples of best practice which have facilitated an effective outbreak response via research in the past. These can be replicated or adapted. This chapter will consider these common themes and discuss relevant examples that can facilitate timely, relevant, and clinically meaningful research on therapeutics during an outbreak.
- Open Access
- 8 July 2022
- Published by Elsevier in IJID Regions
- Vol. 4, 123-130
Bacterial coinfection and antimicrobial use among patients with COVID-19 infection in a referral center in the Philippines: A retrospective cohort study
- 8 July 2022
- Published by Elsevier in IJID Regions
- Vol. 4, 123-130
Open AccessBacterial coinfection and antimicrobial use among patients with COVID-19 infection in a referral center in the Philippines: A retrospective cohort study
- Open Access
- 4 June 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (6) , e0252240
High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey
Setting: The 3rd national tuberculosis (TB) survey in the Philippines in 2007 reported a significant decline in the prevalence of TB. Since then, more significant investments for TB control have been made, yet TB burden estimates from routine surveillance data remain relatively stable. Objective: To estimate the prevalence of bacteriologically confirmed pulmonary TB in the Philippines amongst individuals aged ≥15 years in 2016. Design: In March–December 2016, we conducted a population-based survey with stratified, multi-stage cluster sampling of residents in 106 clusters aged ≥15 years. Survey participants were screened for TB by symptom-based interview and digital chest X-ray. Those with cough ≥2 weeks and/or haemoptysis and/or chest X-ray suggestive of TB were requested to submit 2 sputum specimens for Xpert MTB/RIF, direct sputum smear microscopy using LED fluorescent microscopy, and mycobacterial solid culture (Ogawa method). Bacteriologically confirmed pulmonary TB was defined as MTB culture positive and/or Xpert positive. Results: There were 46,689 individuals interviewed, and 41,444 (88.8%) consented to a chest X-ray. There were 18,597 (39.8%) eligible for sputum examination and 16,242 (87.3%) submitted at least one specimen. Out of 16,058 sputum-eligible participants, 183 (1.1%) were smear-positive. There were 466 bacteriologically confirmed TB cases: 238 (51.1%) Xpert positive, 69 (14.8%) culture positive, and 159 (34.1%) positive by both Xpert and culture. The estimated TB prevalence per 100,000 population aged ≥15 years was 434 (95% CI: 350−518) for smear-positive TB, and 1,159 (95% CI: 1,016−1,301) for bacteriologically confirmed TB. Conclusion: This nationally representative survey found that the TB burden in the Philippines in 2016 was higher than estimated from routine TB surveillance data. There was no evidence of a decline in smear and culture positive TB from the 2007 survey despite significant investments in TB control. New strategies for case-finding and patient-centered care must be intensified and expanded.
- 4 June 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (6) , e0252240
Open AccessHigh TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey
Setting: The 3rd national tuberculosis (TB) survey in the Philippines in 2007 reported a significant decline in the prevalence of TB. Since then, more significant investments for TB control have been made, yet TB burden estimates from routine surveillance data remain relatively stable. Objective: To estimate the prevalence of bacteriologically confirmed pulmonary TB in the Philippines amongst individuals aged ≥15 years in 2016. Design: In March–December 2016, we conducted a population-based survey with stratified, multi-stage cluster sampling of residents in 106 clusters aged ≥15 years. Survey participants were screened for TB by symptom-based interview and digital chest X-ray. Those with cough ≥2 weeks and/or haemoptysis and/or chest X-ray suggestive of TB were requested to submit 2 sputum specimens for Xpert MTB/RIF, direct sputum smear microscopy using LED fluorescent microscopy, and mycobacterial solid culture (Ogawa method). Bacteriologically confirmed pulmonary TB was defined as MTB culture positive and/or Xpert positive. Results: There were 46,689 individuals interviewed, and 41,444 (88.8%) consented to a chest X-ray. There were 18,597 (39.8%) eligible for sputum examination and 16,242 (87.3%) submitted at least one specimen. Out of 16,058 sputum-eligible participants, 183 (1.1%) were smear-positive. There were 466 bacteriologically confirmed TB cases: 238 (51.1%) Xpert positive, 69 (14.8%) culture positive, and 159 (34.1%) positive by both Xpert and culture. The estimated TB prevalence per 100,000 population aged ≥15 years was 434 (95% CI: 350−518) for smear-positive TB, and 1,159 (95% CI: 1,016−1,301) for bacteriologically confirmed TB. Conclusion: This nationally representative survey found that the TB burden in the Philippines in 2016 was higher than estimated from routine TB surveillance data. There was no evidence of a decline in smear and culture positive TB from the 2007 survey despite significant investments in TB control. New strategies for case-finding and patient-centered care must be intensified and expanded.
- 1 May 2015
- Published by Elsevier in Value in Health
- Vol. 18 (3) , A225
Assessing the cost-effectiveness of a Universal Rotavirus Vaccination program for the Philippines using a dynamic transmission model
- 1 May 2015
- Published by Elsevier in Value in Health
- Vol. 18 (3) , A225
Assessing the cost-effectiveness of a Universal Rotavirus Vaccination program for the Philippines using a dynamic transmission model